
Quest Health, Rimidi Partner to Improve Diabetes RPM Outcomes
Early data reveals 11% average blood glucose reduction and up to 1% A1C improvement for participating patients after just two months Quest Health Solutions, a

Early data reveals 11% average blood glucose reduction and up to 1% A1C improvement for participating patients after just two months Quest Health Solutions, a

Rimidi, Inc., a market-leading digital health company that supports healthcare providers in the delivery of remote patient monitoring and chronic disease management with EHR-integrated software,